• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Azithromycin is not associated with increased cardiovascular death in low-risk groups

bys25qthea
May 3, 2013
in Cardiology, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Use of azithromycin did not increase risk of cardiovascular death (CVD) in a general population of young and middle-aged adults. 

Evidence Rating Level: 2 (Good) 

Study Rundown: The study finds that azithromycin is not associated with higher risk of cardiovascular death (CVD) in a general young and middle-aged population. In contrast, the Ray, et al study (see Relevant Reading) showed near 3-fold increase in CVD with azithromycin use in high risk patients. The message is one of risk stratification – azithromycin is safe for the general population with a low baseline risk of cardiovascular disease, while one must weigh benefits against potential risks in high-risk patients prone to cardiac dysrhythmias.

Click to read the study in NEJM

Relevant Reading: Azithromycin and the risk of cardiovascular death

In-Depth [historical cohort study]: This study assessed the risk of death from cardiovascular causes associated with azithromycin use in a general population of young and middle-aged adults. The study compared rate of cardiovascular death (CVD) between the azithromycin group and no-use-of-antibiotics group, as well as between azithromycin and penicillin V groups.

RELATED REPORTS

Addition of azithromycin to standard treatment does not improve survival in childhood diarrhea

Wellness Check: Nutrition

Mass administration of three-dose azithromycin reduces community prevalence of yaws

The risk of CVD was significantly higher with current use (1 to 5 days, starting from the index date) of azithromycin compared to no use of antibiotics (rate ratio, RR, 2.85), this RR increases to 3.27 in sensitivity analysis (SA). Noncardiovascular death rate was also higher with current use of azithromycin (RR=1.60). In contrast, current use of azithromycin did not show a higher rate of CVD than penicillin V (RR=0.93 after adjusting for propensity scores; 95% CI, 0.56 to 1.55). This adjusted RR increased to 1.06 in SA.

The study concludes that azithromycin use is not associated with increased risk of CVD in a general young and middle-aged population.

By Xiaozhou Liu and Andrew Bishara

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: azithromycin
Previous Post

Patient satisfaction a poor surgical quality indicator

Next Post

School programs successfully cut number of smokers

RelatedReports

Growth Faltering is Associated With Altered Brain Functional Connectivity and Cognitive Outcomes In Urban Bangladeshi Children Exposed to Early Adversity
Pediatrics

Addition of azithromycin to standard treatment does not improve survival in childhood diarrhea

February 18, 2022
Provision of medically-tailored meals linked with lower admissions and medical spending
Wellness

Wellness Check: Nutrition

February 17, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Chronic Disease

Mass administration of three-dose azithromycin reduces community prevalence of yaws

January 17, 2022
#VisualAbstract: Azithromycin does not improve clinical outcomes in high-risk patients with suspected COVID-19 in the community setting
StudyGraphics

#VisualAbstract: Azithromycin does not improve clinical outcomes in high-risk patients with suspected COVID-19 in the community setting

April 7, 2021
Next Post
School programs successfully cut number of smokers

School programs successfully cut number of smokers

Gestational weight loss may improve outcomes for obese women

Gestational weight loss may improve outcomes for obese women

Selective estrogen receptor modulators reduce breast cancer risk even after treatment

Selective estrogen receptor modulators reduce breast cancer risk even after treatment

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Evaluation of medical school parental leave policies in the United States
  • Adjuvant S-1 increases short-term survival in patients with resected biliary tract cancer
  • Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options